David Malcom Rodman, Chief Medical Officer: Mineralys Therapeutics MLYS Planned sale · Filed 03/13

Trade details

Type: Planned sale notice
Stock: Mineralys Therapeutics MLYS
Person: David Malcom RodmanChief Medical Officer
Planned sale date: 26/03/13
Filed: 26/03/13

More to sell after $11.1M in 3 months

Mineralys Therapeutics trades, last 26 weeks

What else happened in Mineralys Therapeutics around then

Filed or reported within 30 days of the trade day · 02/11~04/12

David Malcom Rodman's recent trades

David Malcom RodmanChief Medical Officer
Planned sale10b5-1 planMineralys Therapeutics
Planned sale10b5-1 plan
Mineralys Therapeutics
MLYS
$11.7K
417 sh
$11.7K
Filed 09/17
Traded 09/17
David Malcom RodmanChief Medical Officer
Planned sale10b5-1 planMineralys Therapeutics
Planned sale10b5-1 plan
Mineralys Therapeutics
MLYS
$216.9K
7,709 sh
$216.9K
Filed 09/14
Traded 09/14
David Malcom RodmanChief Medical Officer
Planned sale10b5-1 planMineralys Therapeutics
Planned sale10b5-1 plan
Mineralys Therapeutics
MLYS
$67K
2,171 sh
$67K
Filed 09/09
Traded 09/09
David Malcom RodmanChief Medical Officer
Planned sale10b5-1 planMineralys Therapeutics
Planned sale10b5-1 plan
Mineralys Therapeutics
MLYS
$10.6K
417 sh
$10.6K
Filed 08/17
Traded 08/17
David Malcom RodmanChief Medical Officer
Planned sale10b5-1 planMineralys Therapeutics
Planned sale10b5-1 plan
Mineralys Therapeutics
MLYS
$372.2K
14,056 sh
$372.2K
Filed 08/13
Traded 08/13

David Malcom Rodman, Chief Officer — plans to sell 14,058 sh of Mineralys Therapeutics MLYS · $369.2K · around 03/13 · 10b5-1 plan | Whalegun